United Therapeutics CEO sells 9,500 shares around $510
UNITED THERAPEUTICS’ CEO exercised 9,500 options and sold the resulting shares via a pre-arranged Rule 10b5-1 trading plan through family trusts.
Rhea-AI Filing Summary
For UNITED THERAPEUTICS Corp (UTHR), Chairperson & CEO Martine A. Rothblatt reported an exercise of 9,500 stock options at an exercise price of $135.42 per share on September 1, 2026, held indirectly through a family trust. The options converted into 9,500 shares of common stock, which were then sold indirectly by the trust in a series of open-market transactions totaling 9,500 shares at weighted average prices ranging from about $510.43 to $516.57 per share. After the option exercise, the trust reported holding 18,410 stock options of the same series. The filing also lists 40,513 shares of common stock held directly, and 166 shares held indirectly by a spouse. All option exercises and related sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 7, 2025, which continues until the earlier of the exercise of 1,734,410 options expiring March 15, 2027, or December 31, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.60M approx. pre-tax spread)
Exercise and Sale
14 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($4.88M)
Approx. gross sale proceeds
$4.88M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.60M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F12 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 320 | $510.7241 | $163K |
| Sale | Common Stock F1, F4, F2 | 825 | $511.9505 | $422K |
| Sale | Common Stock F1, F5, F2 | 1,732 | $513.1186 | $889K |
| Sale | Common Stock F1, F6, F2 | 3,454 | $514.0927 | $1.78M |
| Sale | Common Stock F1, F7, F2 | 1,620 | $514.983 | $834K |
| Sale | Common Stock F1, F8, F2 | 1,469 | $516.0305 | $758K |
| Sale | Common Stock F1, F2 | 80 | $516.62 | $41K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
| holding | Common Stock F10 | -- | -- | -- |
| holding | Common Stock F11 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 18,410 contracts (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (12)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F11. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F12. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $510.43 to $511.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $511.58 to $512.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $512.59 to $513.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $513.59 to $514.585. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $514.59 to $515.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $515.59 to $516.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Key Figures
Options exercised: 9,500 options
Exercise price: $135.42 per share
Shares sold: 9,500 shares
+5 more
8 metrics
Options exercised
9,500 options
Stock options exercised on September 1, 2026 by a family trust
Exercise price
$135.42 per share
Exercise price of stock options converted into common stock
Shares sold
9,500 shares
Total UTHR common shares sold in multiple trades on September 1, 2026
Sale price range (weighted averages)
$510.43–$516.57 per share
Weighted average price ranges for sale transactions disclosed in footnotes
Remaining options in series
18,410 options
Stock options of the same series held indirectly by a family trust after exercise
Direct common stock holdings
40,513 shares
Common stock held directly by Martine A. Rothblatt as of September 1, 2026
Spousal indirect holdings
166 shares
Common stock held indirectly by spouse as of September 1, 2026
10b5-1 plan option cap
1,734,410 options
Maximum stock options to be exercised under the Rule 10b5-1 plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, family trusts, investment power
4 terms
Rule 10b5-1 trading plan regulatory
"exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
family trusts financial
"Shares held in family trusts as to which the Reporting Person shares investment power"
investment power financial
"shares investment power and the Reporting Person and/or immediate family members are beneficiaries"
FAQ
What insider transactions did UTHR’s CEO report on September 1, 2026?
Martine A. Rothblatt reported exercising 9,500 stock options at $135.42 per share into 9,500 common shares, then selling those 9,500 shares in multiple open-market trades at prices around $510–$517 per share, all through a family trust.
Were the September 1, 2026 UTHR insider trades under a Rule 10b5-1 plan?
Yes. The option exercise and related share sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which continues until the earlier of exercising 1,734,410 options expiring March 15, 2027, or December 31, 2026.
How are family trusts involved in the UTHR insider transactions?
The options and sold shares are held and transacted through family trusts where Martine Rothblatt or her spouse holds investment power and where she and/or immediate family members are beneficiaries, as detailed in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
